[Cardiovascular admissions in Intensive Care Units during COVID-19 pandemic]. 2020

Natalia Vensentini, and Ezequiel J Zaidel, and Adrián Charask, and Simón Salzberg, and Juan Gagliardi, and Joaquín Perea, and Álvaro Sosa Liprandi, and Maximiliano de Abreu, and Javier Mariani, and Carlos D Tajer
Grupo de Estudio, Docencia e Investigación, GEDIC, Argentina. E-mail: nativensen@yahoo.com.

The COVID-19 pandemic has led to measures of social isolation, labor restrictions, a strong information campaign and the suspension of scheduled medical activities. The aim of this study was to describe the impact of these measures on the number of hospitalizations in Cardiovascular Intensive Care Units, with the hypothesis that the social behavior generated by this emergency promotes a decreased demand for medical care, even when severe cardiovascular disease is involved. We compared the number of admissions in March-April 2010-2019 versus March-April 2020, based on a prospective study including six institutions (three public and three private) that use Epi-Cardio® as a multicenter registry of cardiovascular care unit discharge. Altogether, we included 6839 patients discharged during the 11-year study period (2010-2020). The average number of patient admissions on March-April 2010-19 was 595 (CI 95%: 507-683) and decreased to 348 in 2020 (fall of 46.8%, p < 0.001). The reasons for hospitalization were classified into 11 groups and a statistically significant reduction was seen in 10 of these groups: cardiovascular surgery 72.3%, electrophysiological interventions 67.8%, non-ST acute coronary syndromes 52.6%, angioplasties 47.6%, arrhythmias 48.7%, heart failure 46%, atrial fibrillation 35.7%, ST elevation myocardial infarction 34.7%, non cardiac chest pain 31.8%, others 51.6%. Although with low prevalence, hypertensive crisis increased in 89%. The abrupt decrease observed in the number of admissions due to critical pathologies may be considered an "adverse effect" related to the measures adopted, with potentially severe consequences. This trend could be reversed by improving public communication and policy adjustment.

UI MeSH Term Description Entries
D007362 Intensive Care Units Hospital units providing continuous surveillance and care to acutely ill patients. ICU Intensive Care Units,Intensive Care Unit,Unit, Intensive Care
D010343 Patient Admission The process of accepting patients. The concept includes patients accepted for medical and nursing care in a hospital or other health care institution. Voluntary Admission,Admission, Patient,Admission, Voluntary,Admissions, Patient,Admissions, Voluntary,Patient Admissions,Voluntary Admissions
D011024 Pneumonia, Viral Inflammation of the lung parenchyma that is caused by a viral infection. Pneumonias, Viral,Viral Pneumonia,Viral Pneumonias
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000073640 Betacoronavirus A genus of the family CORONAVIRIDAE which causes respiratory or gastrointestinal disease in a variety of mostly mammals. Human betacoronaviruses include HUMAN ENTERIC CORONAVIRUS; HUMAN CORONAVIRUS OC43; MERS VIRUS; and SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS. Members have either core transcription regulatory sequences of 5’-CUAAAC-3’ or 5’-CUAAAC-3’ and mostly have no ORF downstream to the N protein gene. HCoV-HKU1,Human coronavirus HKU1,Pipistrellus bat coronavirus HKU5,Rousettus bat coronavirus HKU9,Tylonycteris bat coronavirus HKU4,Betacoronaviruses
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19

Related Publications

Natalia Vensentini, and Ezequiel J Zaidel, and Adrián Charask, and Simón Salzberg, and Juan Gagliardi, and Joaquín Perea, and Álvaro Sosa Liprandi, and Maximiliano de Abreu, and Javier Mariani, and Carlos D Tajer
September 2020, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine,
Natalia Vensentini, and Ezequiel J Zaidel, and Adrián Charask, and Simón Salzberg, and Juan Gagliardi, and Joaquín Perea, and Álvaro Sosa Liprandi, and Maximiliano de Abreu, and Javier Mariani, and Carlos D Tajer
October 2022, Applied acoustics. Acoustique applique. Angewandte Akustik,
Natalia Vensentini, and Ezequiel J Zaidel, and Adrián Charask, and Simón Salzberg, and Juan Gagliardi, and Joaquín Perea, and Álvaro Sosa Liprandi, and Maximiliano de Abreu, and Javier Mariani, and Carlos D Tajer
July 2022, BMC anesthesiology,
Natalia Vensentini, and Ezequiel J Zaidel, and Adrián Charask, and Simón Salzberg, and Juan Gagliardi, and Joaquín Perea, and Álvaro Sosa Liprandi, and Maximiliano de Abreu, and Javier Mariani, and Carlos D Tajer
November 2020, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine,
Natalia Vensentini, and Ezequiel J Zaidel, and Adrián Charask, and Simón Salzberg, and Juan Gagliardi, and Joaquín Perea, and Álvaro Sosa Liprandi, and Maximiliano de Abreu, and Javier Mariani, and Carlos D Tajer
October 2022, WMJ : official publication of the State Medical Society of Wisconsin,
Natalia Vensentini, and Ezequiel J Zaidel, and Adrián Charask, and Simón Salzberg, and Juan Gagliardi, and Joaquín Perea, and Álvaro Sosa Liprandi, and Maximiliano de Abreu, and Javier Mariani, and Carlos D Tajer
January 2020, Medicina,
Natalia Vensentini, and Ezequiel J Zaidel, and Adrián Charask, and Simón Salzberg, and Juan Gagliardi, and Joaquín Perea, and Álvaro Sosa Liprandi, and Maximiliano de Abreu, and Javier Mariani, and Carlos D Tajer
September 2021, Journal of pediatric intensive care,
Natalia Vensentini, and Ezequiel J Zaidel, and Adrián Charask, and Simón Salzberg, and Juan Gagliardi, and Joaquín Perea, and Álvaro Sosa Liprandi, and Maximiliano de Abreu, and Javier Mariani, and Carlos D Tajer
May 2021, International heart journal,
Natalia Vensentini, and Ezequiel J Zaidel, and Adrián Charask, and Simón Salzberg, and Juan Gagliardi, and Joaquín Perea, and Álvaro Sosa Liprandi, and Maximiliano de Abreu, and Javier Mariani, and Carlos D Tajer
April 2022, Anaesthesia,
Natalia Vensentini, and Ezequiel J Zaidel, and Adrián Charask, and Simón Salzberg, and Juan Gagliardi, and Joaquín Perea, and Álvaro Sosa Liprandi, and Maximiliano de Abreu, and Javier Mariani, and Carlos D Tajer
January 2024, Thorax,
Copied contents to your clipboard!